Chuan Jin
Forskare vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Magnus Essand
- Mobiltelefon:
- 076-266 63 83
- E-post:
- chuan.jin@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA

Publikationer
Senaste publikationer
-
Ingår i Molecular Cancer Therapeutics, s. 469-479, 2026
- DOI för Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
- Ladda ner fulltext (pdf) av Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
-
Ingår i Cancer Gene Therapy, s. 297-305, 2025
- DOI för Biodistribution and toxicity evaluation of oncolytic adenovirus Adf35(OGN) in Syrian hamster and mouse
- Ladda ner fulltext (pdf) av Biodistribution and toxicity evaluation of oncolytic adenovirus Adf35(OGN) in Syrian hamster and mouse
-
Ingår i Cancer Immunology and Immunotherapy, 2025
- DOI för Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
- Ladda ner fulltext (pdf) av Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
-
Ingår i Molecular Therapy Nucleic Acids, 2024
- DOI för Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Ladda ner fulltext (pdf) av Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
-
Ingår i Frontiers in Immunology, 2023
- DOI för Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
- Ladda ner fulltext (pdf) av Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
Alla publikationer
Artiklar i tidskrift
-
Ingår i Molecular Cancer Therapeutics, s. 469-479, 2026
- DOI för Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
- Ladda ner fulltext (pdf) av Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
-
Ingår i Cancer Gene Therapy, s. 297-305, 2025
- DOI för Biodistribution and toxicity evaluation of oncolytic adenovirus Adf35(OGN) in Syrian hamster and mouse
- Ladda ner fulltext (pdf) av Biodistribution and toxicity evaluation of oncolytic adenovirus Adf35(OGN) in Syrian hamster and mouse
-
Ingår i Cancer Immunology and Immunotherapy, 2025
- DOI för Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
- Ladda ner fulltext (pdf) av Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
-
Ingår i Molecular Therapy Nucleic Acids, 2024
- DOI för Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Ladda ner fulltext (pdf) av Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
-
Ingår i Frontiers in Immunology, 2023
- DOI för Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
- Ladda ner fulltext (pdf) av Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
-
A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
Ingår i Frontiers in Molecular Biosciences, 2022
- DOI för A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
- Ladda ner fulltext (pdf) av A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
-
Ingår i Oncoimmunology, 2022
- DOI för Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
- Ladda ner fulltext (pdf) av Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
-
ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression
Ingår i Frontiers in Immunology, 2022
- DOI för ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression
- Ladda ner fulltext (pdf) av ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression
-
Ingår i Nature Biomedical Engineering, s. 830-841, 2022
- DOI för CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
- Ladda ner fulltext (pdf) av CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
-
Ingår i MOLECULAR THERAPY-ONCOLYTICS, s. 356-366, 2021
- DOI för Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
- Ladda ner fulltext (pdf) av Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
-
Ingår i Cell Death and Disease, 2020
- DOI för Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
- Ladda ner fulltext (pdf) av Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
-
Ingår i Journal of Pathology, s. 228-240, 2019
-
Ingår i Oncoimmunology, 2018
- DOI för Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
- Ladda ner fulltext (pdf) av Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
-
Ingår i Oncoimmunology, 2018
-
Ingår i Scandinavian Journal of Immunology, s. 341-341, 2017
-
Ingår i Molecular Therapy, s. 288-288, 2017
-
Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors
Ingår i Immunotherapy, s. 1355-1361, 2016
-
Ingår i CANCER IMMUNOLOGY RESEARCH, 2016
-
Long-term episomal gene transfer for safe engineering of T cells for adoptive cell therapy of cancer
Ingår i CANCER IMMUNOLOGY RESEARCH, 2016
-
Ingår i EMBO Molecular Medicine, s. 702-711, 2016
- DOI för Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
- Ladda ner fulltext (pdf) av Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
-
Ingår i Science Signaling, 2015
-
Long-term episomal gene transfer for safe engineering of T-cells for adoptive cell therapy of cancer
Ingår i Human Gene Therapy, 2014
-
Ingår i Molecular Therapy Methods & Clinical Development, 2014
-
Ingår i Journal of Immunology, s. 2287-2296, 2014
-
Ingår i Molecular Therapy, 2014
-
Ingår i Molecular Therapy, 2014
-
Engineering Regulatory Cells With a T Cell Receptor for Controlled Activation
Ingår i Molecular Therapy, 2014
-
Ingår i PLOS ONE, 2013
- DOI för Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
- Ladda ner fulltext (pdf) av Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
-
Ingår i Human Gene Therapy, s. 766-775, 2013
- DOI för Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
- Ladda ner fulltext (pdf) av Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
-
Ingår i Journal of Virology, s. 13114-13123, 2011
- DOI för Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
- Ladda ner fulltext (pdf) av Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors